Pérez Luis Orlando, Barbisan Gisela, Abba Martín Carlos, Laguens Rubén Martín, Dulout Fernando Noel, Golijow Carlos Daniel
Departamento de Carcinogénesis, Centro de Investigaciones en Genética Básica y Aplicada, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata, Argentina.
Int J Gynecol Pathol. 2006 Jan;25(1):42-7. doi: 10.1097/01.pgp.0000177996.30427.2b.
The aim of the present study was to determine that prevalence of herpes simplex virus (HSV) type 1 and 2 in cervical samples from Argentine women and to assess the role of HSV-2 in cervical cancer. A sample of 79 normal and 200 neoplastic cervical tissues (35 invasive cervical carcinomas, 75 high-grade squamous intraepithelial lesions, 79 low-grade squamous intraepithelial lesions and 11 abnormal squamous cells of undermined significance) was analyzed for herpes simplex and human papillomavirus DNA using the polymerase chain reaction method. Viral genotyping was performed by single strand conformation polymorphisms and restriction fragment length polymorphisms. The overall prevalence of HSV was 21.5% in controls and 29% in cases. Among women with normal cytology, herpes simplex prevalence in HPV positive (20.8%) women was approximately the same as in negative (21.8%) women. HPV- and age- adjusted ORs of high-grade squamous intraepithelial lesions and invasive cervical carcinomas for HSV-2 were 1.4 (p = 0.6) and 1.6 (p = 0.5), respectively. The obtained results indicated that herpes simplex virus may not be involved in cervical cancer development. Future investigations are needed to provided conclusive evidence on the role of this pathogen in cervical cancer.
本研究的目的是确定阿根廷女性宫颈样本中单纯疱疹病毒1型和2型的流行情况,并评估HSV-2在宫颈癌中的作用。使用聚合酶链反应方法对79份正常宫颈组织样本和200份肿瘤性宫颈组织样本(35例浸润性宫颈癌、75例高级别鳞状上皮内病变、79例低级别鳞状上皮内病变和11例意义不明确的异常鳞状细胞)进行单纯疱疹病毒和人乳头瘤病毒DNA分析。通过单链构象多态性和限制性片段长度多态性进行病毒基因分型。对照组中HSV的总体流行率为21.5%,病例组为29%。在细胞学正常的女性中,HPV阳性(20.8%)女性的单纯疱疹病毒流行率与阴性(21.8%)女性大致相同。HSV-2导致高级别鳞状上皮内病变和浸润性宫颈癌的HPV和年龄调整后的优势比分别为1.4(p = 0.6)和1.6(p = 0.5)。所得结果表明单纯疱疹病毒可能不参与宫颈癌的发生发展。需要进一步的研究来提供关于这种病原体在宫颈癌中作用的确凿证据。